| 摘要 |
Pharmaceutical compositions for treatment of ischaemic vascular diseases comprise a haemorheologically active calcium antagonist of formula I, <IMAGE> and a pharmaceutically acceptable carrier, wherein R1 is H, C1-6 alkyl, alkenyl or alkinyl, cycloalkyl, phenylalkyl or phenylalkenyl, wherein the phenyl ring may be substituted by halogen, alkyl, hydroxy or alkoxy; R3 and R4 are as for R1, or may be alkoxy, alkenoxy or alkinoxy; R2 and R5 are each hydrogen or alkyl, R6 is H, halogen, alkyl, alkoxy,alkylsulphonyl or alkylthio, and X is oxygen or sulphur. |
